Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
01 04 2020
Historique:
pubmed: 12 2 2020
medline: 26 1 2021
entrez: 12 2 2020
Statut: ppublish

Résumé

To provide guidelines for the accurate pathologic diagnosis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), the preoperative evaluation of the patient with suspected BIA-ALCL, and the pathologic evaluation of the capsulectomy specimen. To better inform patients and healthcare providers about BIA-ALCL, we convened to review diagnostic procedures used in the evaluation of patients with suspected BIA-ALCL. We focused on the processing of the seroma fluid/effusion surrounding the implant, the handling of capsulectomy specimens following removal of implant(s), and the preoperative evaluation of the patient with suspected BIA-ALCL. Recommendations were based on the published literature and our experience to optimize procedures to obtain an accurate diagnosis and assess for tumor invasion and the extent of the disease. Early diagnosis of BIA-ALCL is important as the disease can progress and deaths have been reported. Because the most common presentation of BIA-ALCL is swelling of the breast with fluid collection, an accurate diagnosis requires cytologic evaluation of the effusion fluid surrounding the affected implant. The first priority is cytocentrifugation and filtration of fresh, unfixed effusion fluid to produce air-dried smears that are stained with Wright-Giemsa or other Romanowsky-type stains. Preparation of a cell block is desirable to allow for hematoxylin and eosin staining and immunohistochemical analysis of formalin-fixed, paraffin-embedded histologic sections. Cell block sections can be used for polymerase chain reaction-based investigation of T-cell receptor gene rearrangement to detect clonality. Fixation and mapping of the capsulectomy specimen to select multiple representative sections are advised to assess for microscopic tumor involvement and capsular invasion. It is appropriate to assess lymph node involvement by excisional biopsy material rather than fine needle aspiration, due to propensity for focal involvement.

Identifiants

pubmed: 32045544
doi: 10.1200/JCO.19.02778
pmc: PMC7106983
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

1102-1111

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Plast Reconstr Surg. 2015 Mar;135(3):695-705
pubmed: 25490535
Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell L):65S-73S
pubmed: 30817558
Diagn Cytopathol. 2016 Jul;44(7):623-7
pubmed: 27079579
Oncotarget. 2018 Nov 16;9(90):36126-36136
pubmed: 30546832
Plast Reconstr Surg. 1997 Aug;100(2):554-5
pubmed: 9252643
Am J Surg Pathol. 2005 Apr;29(4):506-11
pubmed: 15767806
Plast Reconstr Surg. 2011 Sep;128(3):112e-118e
pubmed: 21775924
Plast Reconstr Surg. 2019 May;143(5):1298-1306
pubmed: 31033810
J Natl Compr Canc Netw. 2022 Mar;20(3):285-308
pubmed: 35276674
J Clin Oncol. 2014 Jan 10;32(2):114-20
pubmed: 24323027
Plast Reconstr Surg. 2019 Sep;144(3):610-613
pubmed: 31461013
JAMA Oncol. 2018 Mar 01;4(3):335-341
pubmed: 29302687
Blood. 2014 Aug 28;124(9):1473-80
pubmed: 24894770
Am J Pathol. 1986 May;123(2):256-63
pubmed: 3486598
Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell L):41S-50S
pubmed: 30817555
Am J Surg Pathol. 2017 Mar;41(3):299-312
pubmed: 28195879
Virchows Arch. 2018 Oct;473(4):505-511
pubmed: 29637270
Mod Pathol. 2019 Feb;32(2):166-188
pubmed: 30206414
Am J Surg Pathol. 2008 Sep;32(9):1299-309
pubmed: 18636016
Cytopathology. 2018 Jun;29(3):294-299
pubmed: 29633403
J Clin Oncol. 2016 Jan 10;34(2):160-8
pubmed: 26628470
Semin Diagn Pathol. 2018 Jan;35(1):20-33
pubmed: 29150219
Leukemia. 2003 Dec;17(12):2257-317
pubmed: 14671650
Plast Reconstr Surg. 2017 May;139(5):1042-1050
pubmed: 28157769
JAMA. 2008 Nov 5;300(17):2030-5
pubmed: 18984890
Mod Pathol. 2020 Mar;33(3):367-379
pubmed: 31383966
Aesthet Surg J. 2018 Jun 13;38(7):
pubmed: 29635424
Am J Surg Pathol. 2012 Nov;36(11):1729-34
pubmed: 23073330
Breast Cancer Res Treat. 2014 Aug;147(1):1-14
pubmed: 25073777
Am J Surg Pathol. 2004 Jun;28(6):736-47
pubmed: 15166665
Am J Surg Pathol. 2012 Jul;36(7):1000-8
pubmed: 22613996
Haematologica. 2016 Sep;101(9):e387-90
pubmed: 27198716
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Cytopathology. 2019 Jul;30(4):363-369
pubmed: 30628128
Blood. 2018 Aug 2;132(5):544-547
pubmed: 29921615
Virchows Arch. 2019 Aug;475(2):163-174
pubmed: 30953147
Curr Opin Oncol. 2018 Sep;30(5):292-300
pubmed: 30096095
Ann Oncol. 2016 Feb;27(2):306-14
pubmed: 26598546
Histopathology. 2015 Dec;67(6):925-7
pubmed: 25974645

Auteurs

Elaine S Jaffe (ES)

Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

Binita S Ashar (BS)

Office of Surgical and Infection Control Devices, Office of Product Evaluation and Quality, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.

Mark W Clemens (MW)

Department of Plastic Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Andrew L Feldman (AL)

Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN.

Philippe Gaulard (P)

Department of Pathology, Hôpital Henri Mondor, Institut National de la Santé et de la Recherche Médicale U955, Université Paris-Est, Créteil, France.

Roberto N Miranda (RN)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Aliyah R Sohani (AR)

Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Timothy Stenzel (T)

Office of In Vitro Diagnostics and Radiological Health, Office of Product Evaluation and Quality, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD.

Sung W Yoon (SW)

Office of Surgical and Infection Control Devices, Office of Product Evaluation and Quality, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH